  Jarrow Fem-Dophilus
 Jarrow Fem-Dophilus 30 caps. Promotes Vaginal Health Naturally. Restores beneficial Lactobacillus populations in the
vaginal tract.
Fem-Dophilus and Bone-Up Win Better Nutrition Magazine's
"Best of Supplements" Award! Fem Dophilus, the only oral probiotic clinically documented to restore and maintain a healthy vaginal flora and, and Bone-Up, a complete nutritional regimen for bones and joints, has won Better Nutrition Magazine’s 2008 “Best of Supplements” Award.
The award recognized outstanding supplement products in categories ranging from heart health and immunity to pain relief and cancer prevention.
Better Nutrition Magazine selected the winning products by conducting extensive interviews with a panel of experts, including naturopaths, medical doctors, and experts in the supplement industry. These experts also completed a comprehensive supplement survey and provided feedback on various supplements in 31 categories.
Fem-Dophilus features the world's most documented probiotic strains for women's health, Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ discovered and developed by Drs. Gregor Reid and Andrew Bruce of Urex Biotech, Inc., and is produced and marketed globally by Chr. Hansen, a world leader in probiotics.
Extensive research has confirmed that GR-1™ and RC-14™ taken as an oral supplement colonize and protect the vaginal tract*. More than 20 years of research has shown that GR-1 and RC-14 help to restore and maintain the balance of flora important to vaginal health and the health of the urinary tract overall.
fem-dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1™ and RC-14® to colonize and protect the vaginal tract.*
Clinical trials have shown that GR-1™ and RC-14®:
Help to maintain or restore healthy vaginal flora which is important in maintaining vaginal health.*
Support the health of the urinary tract.*
fem-dophilus is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency. The probiotic strains in fem-dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.
Research has confirmed that GR-1™ and RC-14® taken as an oral supplement colonize and protect the vaginal and urinary
tracts.* Over twenty years of clinical trials has shown that GR-1™ and RC-14® help to restore and maintain the balance of flora important to vaginal health and the health of the urinary tract overall.*
Clinical studies confirm that 1 capsule of GR-1®/RC-14TM (Fem-Dophilus®) taken daily supports proper vaginal flora balance and protection of the urinary tract.
Oral Intake of Fem-Dophilus (GR-1TM & RC-14®) Influences Vaginal Flora Balance:*
Research has confirmed that oral supplementation with friendly probiotic bacteria is important for many health
reasons. Users of other Jarrow Formulas’ probiotics products such as Jarro-Dophilus EPS™ are already aware of the many health benefits that can be experienced from supplementing with beneficial bacteria, i.e. probiotics. Less well-known is the fact that specific strains of probiotic bacteria active in the digestive tract also contribute to vaginal health.*
It has been established that women with an unbalanced intestinal microflora profile are at a higher risk of developing unbalanced urogenital microflora as well (i.e. Lactobacilli-deficient vaginal microflora). Researchers have shown that good vaginal health is associated with a Lactobacilli-dominant vaginal microflora. Fortunately, scientific findings have documented that oral supplementation with probiotic strains GR-1™ and RC-14® taken by mouth at the rate of one capsule per day resulted in vaginal colonization within one week, and significant results were observed within four weeks in terms of an increase in “friendly” Lactobacilli organisms and a reduction in less desirable flora. In clinical
trials, this has translated to positive reports by the probiotic-supplemented subjects regarding their vaginal health at rates twice those found with placebo.*
Protection from Stomach Acids*:
In order for an oral probiotic capsule to be effective, significant numbers of live bacteria (indicated as Colony Forming Units or CFU) must survive through the stomach and upper intestinal tract to the lower intestine where
probiotic bacteria exert their full benefits. Fem-Dophilus incorporates a proprietary polysaccharide matrix that protects the beneficial bacteria from gastric acids and bile during the journey through the stomach into the intestinal tract.*
Clinical Study Highlights:
The major criteria required in selecting beneficial probiotic strains for urogenital health are their ability to colonize the vagina and reduce undesirable vaginal microflora. In one trial, GR-1™ and RC-14® administered in skim milk were given orally to 10 women twice daily for 14 days. GR-1™ and RC- 14® were recovered from the vagina and identified by morphology and molecular typing within one week of commencement of the trial, thus demonstrating that these strains, when taken orally, are able to colonize the vaginal tract within 7 days of initial intake.1 In another randomized, placebo controlled trial, GR-1™ and RC-14® were given to 64 women for 60 days. Microscopy analysis showed the restoration of healthy vaginal flora in 37% of women taking GR-1™ and RC-14® vs. 13% in subjects in placebo group.2
Ingredients:
Each capsule of Fem-Dophilus is guaranteed to contain a minimum combined total of 5 billion live Colony Forming Units (CFU) of Lactobacillus rhamnosus GR-1™** and Lactobacillus reuteri RC-14®**, incorporated into a proprietary protective polysaccharide matrix to maximize survival of the strains through stomach acid and bile.*
The other ingredients in Fem-Dophilus include dextrose anhydrate, potato starch, microcrystalline cellulose and magnesium stearate (vegetable source). Capsule consists of gelatin and titanium dioxide.
Contains: Dairy (casein, in trace amounts).
*Guaranteed 5 Billion live organisms per capsule when kept refrigerated.
Keep out of the reach of children.
KEEP RERIGERATED.
Suggested Use: Take 1 capsule daily for maintenance and increase to 2 capsules a day as needed, or use as directed by your qualified health care consultant.
**GR-1™ brand and RC-14® brand lactobacillus strains are trademarks of Urex Biotech, Inc. used by Jarrow Formulas
under license from Chr. Hansen A/S and protected by Urex Biotech Inc. and BioGaia AB US patents, including 6,479,051
and 5,849,289.
1. Reid, G; Bruce, AW; Fraser, N; Heineman, C; Owen, J; Henning, B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001, 30(1):49-52.
2. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, PoehnerR, Bruce AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum (reuteri) RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS. Immunol Med Microbiol. 2003, 20;35(2):131-4.
| |
|
